Please join us at the Oppenheimer virtual Biotech Emerging Science Summit, featuring Stanford University’s SPARK program, taking place on Thursday, October 17th, 2024.
Date and time of the online event: 17.10. 2024, 11:15 CET
You can register for the event using the button below:
The event will feature multiple experts in the field of longevity research including 4 Stanford University Medical School faculty, as well as presentations from management of companies involved in the longevity space including BioAge and Turn Bio. There will also be a panel discussion with several authorities on investing in longevity.
Speakers：
Jeewon Kim, PhD, MBA, Associate Director of Business Development, SPARK Translational Research Program, Stanford University
Dr. Kim is a science-trained business developer and her interests include the translation of promising academic discoveries (indication-agnostic) into novel therapeutics and diagnostics and discovery, development of new drugs, biologics, and diagnostics and repurposing existing drugs for novel targets for new clinical indications.
Professor Katrin Andreasson, MD, Professor of Neurology & Neurological Sciences
Dr. Andreasson is a neurologist who treats patients with dementia and is also engaged in basic research in neurodegenerative disorders.
Kristen Fortney, PhD, Co-Founder, CEO of BioAge
Dr. Fortney has served as CEO and board member of BioAge since co-founding the company in 2015. Kristen is a scientifically trained biotech executive with extensive experience building discovery platforms, building teams, fundraising, and scientific & clinical strategy.
Professor Katrin Svensson, PhD, Asst. Prof. of Pathology, Affinity Group Leader, Stanford Diabetes Research Center
Prof. Svensson is Assistant Professor of Pathology at Stanford University and one of the Affinity group leaders at the Stanford Diabetes Research Center (SDRC).
Professor Jonathan Long, PhD, Assoc. Prof. of Pathology and ChEM-H Institute Scholar
Prof. Long received his BA from Columbia University in NYC. He completed his PhD at The Scripps Research Institute in the laboratory of Benjamin F.
A team of scientists led by the head of the research group at the Department of Biology, Nicola Silva, has made a significant achievement in research into the reduced or impaired function of the Synaptonemal complex, which may be one of the causes of sterility. The paper by an international team of authors was published in the prestigious scientific journal Nature Communications in March 2025.
SPARK Europe Webinar Series | 2nd April 2025 |4-5 pm (CET) | Regulatory considerations of C&G Therapies | Suzanne Einmahl | hosted by SPARK Zürich
